INBX Inhibrx Biosciences, Inc. - Common Stock
$98,91
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$22–$155
58% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$278
+181% upside
P/E (TTM)
-11.0
ROE
-365.9%
Nettogewinnmarge
-10773.5%
INBX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$98.91
Marktkapitalisierung
$1.44B
P/E (TTM)
-11.0
EPS (TTM)
$-9.04
Umsatz (TTM)
$1M
Dividendenrendite
—
ROE
-365.9%
Verschuldungsgrad
12.6
52W-Spanne
$22 – $155
INBX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$1M
2023-12-31
→
2025-12-31
EPS
$-9.04
2023-12-31
→
2025-12-31
Freier Cashflow
$-130M
2024-12-31
→
2025-12-31
Margen
-10773.5%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
INBX
Peer-Median
P/E (TTM)
-11.0
—
P/S (TTM) (K/V (TTM))
1111.4
30.7
P/B (K/B)
180.8
3.6
EV / EBITDA
-10.7
—
Price / FCF (Kurs / FCF)
-11.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
INBX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-10386.5%
—
Net Profit Margin (Nettogewinnmarge)
-10773.5%
-638.9%
ROA
-85.6%
-40.9%
ROE
-365.9%
-47.9%
ROIC
-124.4%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
INBX
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
12.6
—
Current Ratio (Liquiditätsgrad)
3.9
8.3
Quick Ratio
3.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
INBX
Peer-Median
Revenue YoY (Umsatz YoY)
550.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
INBX
Peer-Median
INBX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 3 33,3%
- Kauf 4 44,4%
- Halten 2 22,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
2 Analysten · 2026-08-17
Median
$277.50
← Unter allen Zielen
$98.91
Tief
$230.00
Hoch
$325.00
Median-Ziel
$277.50
+180,6%
Mittelwert-Ziel
$277.50
+180,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-2.15 | $-1.82 | -0.33% |
| 31. Dezember 2025 | $-2.11 | $-2.12 | 0.01% |
| 30. September 2025 | $-2.28 | $-1.75 | -0.53% |
| 30. Juni 2025 | $-1.85 | $-2.82 | 0.97% |
| 31. März 2025 | $-2.80 | $-2.90 | 0.10% |
| 31. Dezember 2024 | $-3.09 | $-2.94 | -0.15% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| PURR | — | — | — | — | — | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| AKTS | — | — | — | — | — | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1M | $200.0K | $2M | |
| R&D Expense | $113M | $204M | $192M | |
| SG&A Expense | $23M | $128M | $29M | |
| Operating Expenses | $136M | $332M | $221M | |
| Operating Income | $-135M | $-331M | $-219M | |
| Other Non-op | $-381.0K | $75.0K | $-580.0K | |
| Pretax Income | $-140M | $1.69B | $-240M | |
| Income Tax | $2.0K | $2.0K | $3.0K | |
| Net Income | $-140M | $1.69B | $-241M | |
| EPS (Basic) | $-9.04 | $114.01 | $-20.48 | |
| EPS (Diluted) | $-9.04 | $112.62 | $-20.48 | |
| Shares (Basic) | 15,487,000 | 14,802,000 | 11,783,000 | |
| Shares (Diluted) | 15,487,000 | 14,984,000 | 11,783,000 | |
| EBITDA | $-133M | $-329M | · |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $124M | $153M | $278M | |
| Prepaid Expense | $8M | $7M | $17M | |
| Other Current Assets | $238.0K | $382.0K | $366.0K | |
| Current Assets | $133M | $160M | $295M | |
| PP&E (Net) | $4M | $6M | $6M | |
| PP&E (Gross) | $15M | $15M | $13M | |
| Accum. Depreciation | $11M | $9M | $7M | |
| Other Non-current Assets | $4M | $7M | $3M | |
| Total Assets | $146M | $181M | $308M | |
| Accounts Payable | $6M | $9M | $11M | |
| Accrued Liabilities | $26M | $30M | $43M | |
| Current Liabilities | $34M | $41M | $56M | |
| Capital Leases | $4M | $6M | $1M | |
| Total Liabilities | $138M | $47M | $264M | |
| Total Debt | $101M | $0 | · | |
| Common Stock | $1.0K | $1.0K | $5.0K | |
| Paid-in Capital | $254M | $240M | $657M | |
| Retained Earnings | $-246M | $-106M | $-614M | |
| Stockholders' Equity | $8M | $134M | $44M | |
| Liabilities + Equity | $146M | $181M | $308M | |
| Shares Outstanding | 14,577,609 | 14,476,000 | 47,369,000 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $1M | |
| Stock-based Comp | $11M | $59M | $25M | |
| Other Non-cash | $-3M | $-1.94B | · | |
| Operating Cash Flow | $-130M | $-194M | $-193M | |
| CapEx | $31.0K | $3M | $5M | |
| Investing Cash Flow | $-28.0K | $-3M | $-5M | |
| Financing Cash Flow | $101M | $72M | $202M | |
| Net Change in Cash | $-28M | $-125M | $4M | |
| Taxes Paid | $2.0K | $2.0K | $3.0K | |
| Free Cash Flow | $-130M | $-197M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -10386.5% | -165724.0% | · | |
| Net Margin | -10773.5% | 843786.0% | · | |
| Pretax Margin | -10773.3% | 843787.0% | · | |
| EBITDA Margin | -10195.5% | -164581.5% | · | |
| ROA | -85.6% | 690.7% | · | |
| ROE | -365.9% | 1081.6% | · | |
| ROIC | -124.4% | -248.1% | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.9 | 3.9 | · | |
| Quick Ratio | 3.7 | 3.7 | · | |
| Debt / Equity | 12.6 | 0.0 | · | |
| LT Debt / Equity | 12.6 | 0.0 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 550.0% | -88.9% | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $1M | $200.0K | · | |
| Net Income TTM | $-140M | $1.69B | · | |
| Market Cap | $1.15B | $223M | · | |
| Enterprise Value | $1.13B | $70M | · | |
| P/E | -8.7 | 0.1 | · | |
| P/S | 885.9 | 1114.6 | · | |
| P/B | 144.1 | 1.7 | · | |
| P / Tangible Book | 144.1 | 1.7 | · | |
| P / Cash Flow | -8.9 | -1.1 | · | |
| P / FCF | -8.9 | -1.1 | · | |
| EV / EBITDA | -8.5 | -0.2 | · | |
| EV / FCF | -8.7 | -0.4 | · | |
| EV / Revenue | 867.7 | 351.7 | · | |
| Earnings Yield | -11.4% | 731.3% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | $0 | $0 | $1M | $0 | $100.0K | $0 | $100.0K | $0 | $2M | $119.0K | |
| R&D Expense | $24M | $25M | $25M | $29M | $22M | $37M | $33M | $39M | $68M | $64M | $82M | $38M | |
| SG&A Expense | $8M | $6M | $6M | $5M | $6M | $6M | $17M | $8M | $93M | $10M | $8M | $8M | |
| Operating Expenses | $32M | $31M | $31M | $34M | $29M | $43M | $50M | $47M | $161M | $74M | $90M | $46M | |
| Operating Income | $-32M | $-31M | $-31M | $-34M | $-27M | $-43M | $-50M | $-47M | $-161M | $-74M | $-88M | $-46M | |
| Other Non-op | $-68.0K | $-12.0K | $-39.0K | $-46.0K | $-246.0K | $-50.0K | $60.0K | $41.0K | $33.0K | $-59.0K | $-158.0K | $-135.0K | |
| Pretax Income | $-37M | $-33M | $-33M | $-35M | $-29M | $-43M | $-48M | $-44M | $1.86B | $-79M | $-92M | $-52M | |
| Income Tax | $3.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | $-4.0K | $2.0K | |
| Net Income | $-37M | $-33M | $-33M | $-35M | $-29M | $-43M | $-48M | $-44M | $1.86B | $-79M | $-94M | $-52M | |
| EPS (Basic) | $-2.34 | $-2.15 | $-2.11 | $-2.28 | $-1.85 | $-2.80 | $-4.48 | $-2.84 | $127.10 | $-5.77 | $-7.29 | $-4.39 | |
| EPS (Diluted) | $-2.34 | $-2.15 | $-2.11 | $-2.28 | $-1.85 | $-2.80 | $-4.25 | $-2.84 | $125.48 | $-5.77 | $-7.29 | $-4.39 | |
| Shares (Basic) | 15,669,000 | 15,585,000 | -30,927,000 | 15,478,000 | 15,468,000 | 15,468,000 | -28,924,000 | 15,468,000 | 14,619,000 | 13,639,000 | 582,000 | 11,788,000 | |
| Shares (Diluted) | 15,669,000 | 15,585,000 | -30,927,000 | 15,478,000 | 15,468,000 | 15,468,000 | -28,930,000 | 15,468,000 | 14,807,000 | 13,639,000 | 582,000 | 11,788,000 | |
| EBITDA | $-32M | $-30M | · | $-33M | $-27M | $-42M | · | $-46M | $-160M | · | · | · |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $133M | $162M | $124M | $153M | $187M | $217M | $153M | $196M | $227M | · | $278M | · | |
| Prepaid Expense | $9M | $9M | $8M | $7M | $6M | $7M | $7M | $10M | $14M | · | $17M | · | |
| Other Current Assets | $574.0K | $262.0K | $238.0K | $410.0K | $283.0K | $269.0K | $382.0K | $748.0K | $966.0K | · | $366.0K | · | |
| Current Assets | $142M | $171M | $133M | $161M | $194M | $223M | $160M | $207M | $242M | · | $295M | · | |
| PP&E (Net) | $3M | $3M | $4M | $4M | $5M | $6M | $6M | $7M | $8M | · | $6M | · | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $13M | · | |
| Accum. Depreciation | $12M | $12M | $11M | $11M | $10M | $10M | $9M | $8M | $7M | · | $7M | · | |
| Other Non-current Assets | $5M | $4M | $4M | $6M | $7M | $7M | $7M | $7M | $7M | · | $3M | · | |
| Total Assets | $154M | $184M | $146M | $177M | $212M | $243M | $181M | $223M | $258M | · | $308M | · | |
| Accounts Payable | $10M | $9M | $6M | $7M | $8M | $9M | $9M | $12M | $13M | · | $11M | · | |
| Accrued Liabilities | $16M | $15M | $26M | $27M | $28M | $33M | $30M | $30M | $24M | · | $43M | · | |
| Current Liabilities | $28M | $27M | $34M | $36M | $39M | $44M | $41M | $44M | $39M | · | $56M | · | |
| Capital Leases | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $0 | $0 | · | $1M | · | |
| Total Liabilities | $207M | $205M | $138M | $141M | $144M | $148M | $47M | $44M | $39M | · | $264M | · | |
| Total Debt | $176M | $175M | · | $100M | $99M | $99M | · | $0 | $0 | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | $5.0K | · | |
| Paid-in Capital | $263M | $259M | $254M | $250M | $247M | $244M | $240M | $237M | $234M | · | $657M | · | |
| Retained Earnings | $-316M | $-280M | $-246M | $-213M | $-178M | $-149M | $-106M | $-58M | $-14M | · | $-614M | · | |
| Stockholders' Equity | $-53M | $-21M | $8M | $37M | $69M | $94M | $134M | $178M | $219M | · | $44M | · | |
| Liabilities + Equity | $154M | $184M | $146M | $177M | $212M | $243M | $181M | $223M | $258M | · | $308M | · | |
| Shares Outstanding | 14,708,910 | 14,607,286 | 14,577,609 | 14,498,093 | 14,475,904 | 14,475,904 | 14,475,904 | 14,475,904 | 14,475,904 | · | 47,369,511 | · |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $523.0K | $537.0K | $564.0K | $582.0K | $662.0K | $675.0K | $690.0K | $760.0K | $475.0K | $360.0K | $298.0K | $304.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $46M | $6M | $6M | $7M | |
| Other Non-cash | · | $-8M | · | · | · | $4M | · | · | · | · | · | · | |
| Operating Cash Flow | $-30M | $-38M | $-30M | $-34M | $-30M | $-36M | $-44M | $-30M | $-57M | $-63M | $-57M | $-54M | |
| CapEx | $0 | $0 | $0 | $10.0K | $0 | $21.0K | $16.0K | $247.0K | $1M | $1M | $3M | $811.0K | |
| Investing Cash Flow | $0 | $0 | $0 | $-7.0K | $0 | $-21.0K | $-16.0K | $-247.0K | $-1M | $-1M | $-3M | $-811.0K | |
| Financing Cash Flow | $2M | $75M | $1M | $352.0K | $0 | $100M | $0 | $0 | $33M | $39M | $860.0K | $200M | |
| Net Change in Cash | $-28M | $37M | $-29M | $-33M | $-30M | $64M | $-44M | $-31M | $-26M | $-25M | $-59M | $145M | |
| Taxes Paid | $3.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | · | · | |
| Free Cash Flow | · | $-38M | · | · | · | $-36M | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2106.8% | · | · | · | -160898.0% | · | · | · | |
| Net Margin | · | · | · | · | -2204.2% | · | · | · | 1858011.0% | · | · | · | |
| Pretax Margin | · | · | · | · | -2204.0% | · | · | · | 1858013.0% | · | · | · | |
| EBITDA Margin | · | · | · | · | -2055.9% | · | · | · | -160423.0% | · | · | · | |
| ROA | -20.0% | -15.7% | · | -17.6% | -12.2% | -35.7% | · | -39.4% | 1438.0% | · | · | · | |
| ROE | -470.4% | -91.1% | · | -32.8% | -19.9% | -91.7% | · | -49.2% | 1694.0% | · | · | · | |
| ROIC | -26.1% | -20.1% | · | -24.7% | -16.3% | -22.2% | · | -26.2% | -73.4% | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 6.5 | · | 4.5 | 5.0 | 5.1 | · | 4.7 | 6.2 | · | · | · | |
| Quick Ratio | 4.8 | 6.1 | · | 4.3 | 4.8 | 5.0 | · | 4.5 | 5.8 | · | · | · | |
| Debt / Equity | -3.3 | -8.3 | · | 2.7 | 1.4 | 1.0 | · | 0.0 | 0.0 | · | · | · | |
| LT Debt / Equity | -3.3 | -8.3 | · | 2.7 | 1.4 | 1.0 | · | 0.0 | 0.0 | · | · | · |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1M | · | $1M | $1M | $100.0K | · | $219.0K | $249.0K | · | · | · | |
| Net Income TTM | $-134M | $-141M | · | $-151M | $1.74B | $1.69B | · | $1.68B | $1.68B | · | · | · | |
| Market Cap | $1.39B | $982M | · | $488M | $207M | $203M | · | $227M | $205M | · | · | · | |
| Enterprise Value | $1.44B | $995M | · | $435M | $119M | $85M | · | $30M | $-22M | · | · | · | |
| P/E | -11.0 | -7.4 | · | -3.4 | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | |
| P/S | · | 755.4 | · | 375.6 | 147.6 | 2025.2 | · | 1035.1 | 823.8 | · | · | · | |
| P/B | -26.3 | -46.7 | · | 13.3 | 3.0 | 2.1 | · | 1.3 | 0.9 | · | · | · | |
| P / Tangible Book | · | · | · | 13.3 | 3.0 | 2.1 | · | 1.3 | 0.9 | · | · | · | |
| P / Cash Flow | · | -25.8 | · | · | · | -5.6 | · | · | · | · | · | · | |
| P / FCF | · | -25.8 | · | · | · | -5.6 | · | · | · | · | · | · | |
| EV / EBITDA | -45.4 | -32.8 | · | -13.1 | -4.5 | -2.0 | · | -0.7 | 0.1 | · | · | · | |
| EV / FCF | · | -26.2 | · | · | · | -2.4 | · | · | · | · | · | · | |
| EV / Revenue | · | 765.7 | · | 334.7 | 85.2 | 846.5 | · | 138.6 | -87.3 | · | · | · | |
| Earnings Yield | -9.1% | -13.5% | · | -29.0% | 826.8% | 815.4% | · | 718.3% | 783.4% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Umsatz | $1M | $200.0K | $2M |
| Betriebsgewinnmarge % | -10386.5% | -165724.0% | — |
| Nettoergebnis | $-140M | $1.69B | $-241M |
| Verwässerte EPS | $-9.04 | $112.62 | $-20.48 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Fremdkapital / Eigenkapital | 12.6 | 0.0 | — |
| Liquiditätsgrad | 3.9 | 3.9 | — |
| Quick Ratio | 3.7 | 3.7 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-130M | $-197M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 180 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 56 (+35 vs. Vorquartal) | 19 (-6 vs. Vorquartal) | 55 (+7 vs. Vorquartal) | 41 (-2 vs. Vorquartal) | +2.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $122.963.044 | 1.297.763 | 10,26% | Aktien |
| Sanofi | $109.713.489 | 1.157.926 | 9,15% | Aktien |
| VIKING GLOBAL INVESTORS LP | $106.492.273 | 1.123.929 | 8,88% | Aktien |
| HighTower Advisors, LLC | $82.484.676 | 870.551 | 6,88% | Aktien |
| BANK OF AMERICA CORP /DE/ | $78.813.808 | 831.808 | 6,57% | Aktien |
| Schonfeld Strategic Advisors LLC | $66.096.272 | 697.586 | 5,51% | Aktien |
| STATE STREET CORP | $60.683.396 | 640.458 | 5,06% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $46.662.196 | 492.477 | 3,89% | Aktien |
| VANGUARD GROUP INC | $43.911.597 | 555.843 | 3,66% | Aktien |
| Woodline Partners LP | $37.984.517 | 400.892 | 3,17% | Aktien |
| Capital Research Global Investors | $34.398.988 | 363.050 | 2,87% | Aktien |
| PFM Health Sciences, LP | $29.219.479 | 308.385 | 2,44% | Aktien |
| Sofinnova Investments, Inc. | $28.719.009 | 303.103 | 2,40% | Aktien |
| GOLDMAN SACHS GROUP INC | $25.777.685 | 272.060 | 2,15% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $25.743.575 | 271.700 | 2,15% | Aktien |
| Parkman Healthcare Partners LLC | $24.346.013 | 256.950 | 2,03% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $20.929.309 | 220.830 | 1,75% | Aktien |
| First Turn Management, LLC | $15.613.189 | 164.783 | 1,30% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $13.947.200 | 147.200 | 1,16% | Aktien |
| CDC Financial, Inc. | $13.277.318 | 140.130 | 1,11% | Aktien |
| FIRST TRUST ADVISORS LP | $12.168.174 | 128.424 | 1,02% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $11.612.276 | 122.557 | 0,97% | Aktien |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $11.294.200 | 119.200 | 0,94% | Aktien |
| NORGES BANK | $8.555.925 | 90.300 | 0,71% | Aktien |
| CITIGROUP INC | $7.122.547 | 75.172 | 0,59% | Aktien |
| Jefferies Financial Group Inc. | $6.956.166 | 73.416 | 0,58% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.840.950 | 72.200 | 0,57% | Kaufoption |
| VANGUARD FIDUCIARY TRUST CO | $6.624.920 | 69.920 | 0,55% | Aktien |
| GOLDMAN SACHS GROUP INC | $6.300.875 | 66.500 | 0,53% | Kaufoption |
| RENAISSANCE TECHNOLOGIES LLC | $5.893.545 | 62.201 | 0,49% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $5.831.389 | 61.545 | 0,49% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $5.669.935 | 59.841 | 0,47% | Aktien |
| Voleon Capital Management LP | $5.529.421 | 58.358 | 0,46% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4.620.484 | 48.765 | 0,39% | Aktien |
| Western Standard LLC | $4.453.250 | 47.000 | 0,37% | Aktien |
| NOMURA HOLDINGS INC | $3.837.375 | 40.500 | 0,32% | Kaufoption |
| Caption Management, LLC | $3.827.900 | 40.400 | 0,32% | Kaufoption |
| CITADEL ADVISORS LLC | $3.534.175 | 37.300 | 0,29% | Kaufoption |
| VICTORY CAPITAL MANAGEMENT INC | $3.452.974 | 36.443 | 0,29% | Aktien |
| ArrowMark Colorado Holdings LLC | $3.332.926 | 35.176 | 0,28% | Aktien |
| UBS Group AG | $3.318.050 | 35.019 | 0,28% | Aktien |
| MORGAN STANLEY | $3.154.891 | 33.297 | 0,26% | Aktien |
| HUSSMAN STRATEGIC ADVISORS, INC. | $2.984.625 | 31.500 | 0,25% | Aktien |
| Empyrean Capital Partners, LP | $2.842.500 | 30.000 | 0,24% | Aktien |
| CDC Financial, Inc. | $2.842.500 | 30.000 | 0,24% | Kaufoption |
| Atom Investors LP | $2.804.032 | 29.594 | 0,23% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.717.241 | 28.678 | 0,23% | Aktien |
| Corient Private Wealth LP | $2.714.873 | 28.653 | 0,23% | Aktien |
| Point72 Asset Management, L.P. | $2.464.542 | 26.011 | 0,21% | Aktien |
| NOMURA HOLDINGS INC | $2.359.275 | 24.900 | 0,20% | Verkaufsoption |
| Informed Momentum Co LLC | $2.186.546 | 23.077 | 0,18% | Aktien |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | $2.139.834 | 22.584 | 0,18% | Aktien |
| Nicholas Investment Partners, LP | $2.031.724 | 21.443 | 0,17% | Aktien |
| Opaleye Management Inc. | $1.922.572 | 20.291 | 0,16% | Aktien |
| JANE STREET GROUP, LLC | $1.819.200 | 19.200 | 0,15% | Kaufoption |
| XTX Topco Ltd | $1.739.894 | 18.363 | 0,15% | Aktien |
| Verition Fund Management LLC | $1.704.837 | 17.993 | 0,14% | Aktien |
| D. E. Shaw & Co., Inc. | $1.667.600 | 17.600 | 0,14% | Kaufoption |
| Quantinno Capital Management LP | $1.648.271 | 17.396 | 0,14% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.636.522 | 17.272 | 0,14% | Aktien |
| SummitTX Capital, L.P. | $1.445.032 | 15.251 | 0,12% | Aktien |
| Laird Norton Wetherby Wealth Management, LLC | $1.369.295 | 40.656 | 0,11% | Aktien |
| Swiss National Bank | $1.317.025 | 13.900 | 0,11% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.222.275 | 12.900 | 0,10% | Verkaufsoption |
| CIGOGNE MANAGEMENT SA | $1.169.353 | 75.932 | 0,10% | Aktien |
| RHUMBLINE ADVISERS | $1.142.299 | 12.056 | 0,10% | Aktien |
| Rafferty Asset Management, LLC | $1.056.273 | 11.148 | 0,09% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $1.054.852 | 11.133 | 0,09% | Aktien |
| D. E. Shaw & Co., Inc. | $1.006.435 | 10.622 | 0,08% | Aktien |
| Ethic Inc. | $885.439 | 9.345 | 0,07% | Aktien |
| Bank of New York Mellon Corp | $832.474 | 8.786 | 0,07% | Aktien |
| WELLS FARGO & COMPANY/MN | $810.207 | 8.551 | 0,07% | Aktien |
| Meridian Wealth Advisors, LLC | $805.375 | 8.500 | 0,07% | Aktien |
| BlackRock, Inc. | $774.960 | 8.179 | 0,06% | Aktien |
| NOMURA HOLDINGS INC | $758.000 | 8.000 | 0,06% | Aktien |
| Vanguard Global Advisers, LLC | $701.340 | 7.402 | 0,06% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $648.770 | 9.650 | 0,05% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $625.445 | 6.601 | 0,05% | Aktien |
| Squarepoint Ops LLC | $619.949 | 6.543 | 0,05% | Aktien |
| MARSHALL WACE, LLP | $613.033 | 6.470 | 0,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $599.389 | 6.326 | 0,05% | Aktien |
| PLATINUM INVESTMENT MANAGEMENT LTD | $582.334 | 6.146 | 0,05% | Aktien |
| Cannon Global Investment Management, LLC | $559.025 | 5.900 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $534.201 | 5.638 | 0,04% | Aktien |
| PROFUND ADVISORS LLC | $532.495 | 5.620 | 0,04% | Aktien |
| ExodusPoint Capital Management, LP | $531.737 | 5.612 | 0,04% | Aktien |
| CITADEL ADVISORS LLC | $511.650 | 5.400 | 0,04% | Verkaufsoption |
| Qube Research & Technologies Ltd | $509.566 | 5.378 | 0,04% | Aktien |
| D. E. Shaw & Co., Inc. | $483.225 | 5.100 | 0,04% | Verkaufsoption |
| Brevan Howard Capital Management LP | $463.328 | 4.890 | 0,04% | Aktien |
| Persium Advisors, LLC | $461.906 | 4.875 | 0,04% | Aktien |
| Dynamic Advisor Solutions LLC | $457.074 | 4.824 | 0,04% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $454.705 | 4.799 | 0,04% | Aktien |
| Balyasny Asset Management L.P. | $447.978 | 4.728 | 0,04% | Aktien |
| Mariner, LLC | $432.908 | 4.569 | 0,04% | Aktien |
| SIG BROKERAGE, LP | $426.375 | 4.500 | 0,04% | Kaufoption |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $415.005 | 4.380 | 0,03% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $405.151 | 4.276 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $398.519 | 4.206 | 0,03% | Aktien |
| Russell Investments Group, Ltd. | $385.064 | 4.064 | 0,03% | Aktien |
Unternehmensinsider 8 Insider · 3 Führungskräfte · 5 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark Lappe | Chief Executive Officer | 30. Mai 2024 A | 14.865 | 0 | 0 | $0 |
| Kelly Deck | Chief Financial Officer | 30. Mai 2024 A | — | 0 | 0 | $0 |
| Brendan P. Eckelman | Chief Scientific Officer | 30. Mai 2024 A | 40.000 | 0 | 0 | $0 |
| Kristiina Vuori MD | Direktor | 3. Juni 2026 A | — | 0 | 0 | $0 |
| Jon Faiz Kayyem | Direktor | 3. Juni 2026 A | 6.250 | 0 | 0 | $0 |
| Douglas Forsyth | Direktor | 3. Juni 2026 A | 149.564 | 0 | 0 | $0 |
| Kimberly Manhard | Direktor | 3. Juni 2026 A | — | 0 | 0 | $0 |
| Inhibrx, Inc. | 10%-Eigentümer | 29. Mai 2024 J | 1.157.926 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| The Jon F. Kayyem and Paige Gates-Kayyem Family Trust, Jon Faiz Kayyem ×2 Einreichungen | 26. Februar 2025 | 7,90% | Änderung | — | SEC |
| Mark Lappe ×2 Einreichungen | 26. Februar 2025 | 6,40% | Änderung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 37 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,20% | 3.467 NS | 30. April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,86% | 69.479 NS | 30. April 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,60% | 10.170 NS | 31. Mai 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,44% | 41.307 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,42% | 16.961 NS | 30. April 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,17% | 6.473 NS | 30. April 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,16% | 1.526 NS | 31. Mai 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,13% | 27.554 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,09% | 796 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,08% | 537 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 80.224 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,07% | 6.357 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,04% | 70.378 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 8.415 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,04% | 3.927 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 10.870 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 54.768 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 242.141 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,02% | 2.904 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,02% | 427 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 3.333 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 334 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 398 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 342 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 110.905 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.460 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 20.879 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,01% | 16.777 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 463 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 363 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 4.908 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 8 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 13.968 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 1.943 SH | 8. August 2026 | Täglich |
| RYLD · Global X Funds | 0,00% | 15.798 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 369.641 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 781 SH | 8. August 2026 | Täglich |